A soluble factor which augments the expression of major histocompatibility complex class I (MHC I) antigens on a number of murine tumor cell lines, has been isolated from the culture supernatants of mixed lymphocyte reaction of spleen cells derived from C57BI/6, Balb/c and Swiss mice. The factor, termed MHC-augmenting factor (MHC-AF) has been partially purified by Sephadex G-100 column chromatography and reverse phase HPLC. MHC-AF activity is associated with an 18 kDa molecule. MHC-AF activity was resistant to pH 2.0 treatment and partially purified MHC-AF preparations did not have any activity in L929 cell/vesicular stomatitis virus (VSV) interferon bioassay system. Antibodies to IFN-did not block the activity of MHC-AF. These results indicate that a MHC-AF distinct from IFN-, is produced by mouse spleen cells undergoing a mixed lymphocyte reaction.
Introduction
Highly polymorphic majot histocompatibility complex (MHC) locus codes for Class I and II molecules which play a central role in immune cell interactions. MHC class I and II molecules present antigen derived peptides to CD8 + and CD4 + subset of T-lymphocytes respectvely (Benham et al., 1995) . In addition, antigen receptors on T-c e l l s (TCR) can recognize antigenic peptides only when the latter is presented in association with self MHC molecules, a phenomenon referred to as MHC restriction (Zinkernagel and Doherty. 1979) . Natural Killer (NK) cells constitute a non-T-non-B class of lymphocytes which spontaneously kill target cells in a MHC nonrestricted manner. Alterations in the expression levels of class I MHC antigens on target cells nonetheless regulates their susceptiblity to NK cell mediated lysis. An inverse correlation between the NK sensitivity of target cells and their levels of expression of class I MHC antigen has reported in many systems (Harel-Bellan et al., 1986; Karre et al., 1986 , Kawano et al., 1986 . Both NK and T cells participate in antitumor immunesurveillance mechanisms and since the class I MHC expression on the tumor cells determines their susceptiblity to these immunesurveillance mechanisms, factors which regulate the expression of the class I MHC antigens on tumor cells, may play an important role in determining the fate of a tumor in vivo.
Many factors are known to modulate class I MHC antigen expression on tumor cells. These include cytokines such as interferon (IFN) (Rosa and Fellows 1984 ; Ta n i g u c h i et al., 1987; Reiter et al., 1988) , in vivo passage of tumor cells (Piontek et al., 1985) and inducers of diff e r e n t i a t i o n , such as phorbol esters and sodium butyrate (Stern et al. , 1980; Gidlund et al., 1981) . We have previously shown that culture supernatants of Con A activated rat spleen cells contain a soluble factor distinct from IFN-γ, which upregulates the expression of class I MHC antigens on some tumor cell lines (Saxena et al., 1988a (Saxena et al., , 1989 . Since Con A itself induces the expression of class I MHC antigens on tumor cells, the possibility remains that the MHC augmenting factor detected in Con A activated culture supernatants was derived from Con A itself. We therefore tried to use mixed lymphocyte reaction (MLR) as a means of activation of spleen cells in order to avoid Con A. In the present study, we have shown that murine MLR culture supernatants contain a soluble factor similar to that described in rat spleen Con A supernatants. We have partially purified and characterized this activity.
Materials and Methods

Animals
Inbred C57BI/6 and Balb/c and outbred Swiss a l b i n o mice (8-12 weeks) were used throughout this study. All animals were bred and maintained in the Animal House Facility in Jawaharlal Nehru University, New Delhi.
(complete medium). The complete media used for generation of MLR culture supernatant were either RPMI-1640 from Sigma supplemented with 2% fetal calf serum, 2 1 0 -5 M mercaptoethanol, 300 μg/ml gultamine and 60 μg/ml gentamicin (Complete medium or CM), or serum free DCCM-2 medium (Biological Industries, Israel) supplemented with 2 1 0 -5 M 2-mercaptoethanol, 300 μg/ml gultamine and 60 μg/ml gentamicin (Serum free Complete Medium, SF-CM).
Monoclonal antibodies and antibody c o n j u g a t e s
Supernatants from hybridoma cell lines HB102 (secreting a n t i -H -2 D d ), HB170 (secreting anti-IFNγ), B468 (secreting anti-H-2K k ) and B896 (secreting anti-H-2K b ) were used as a source of monoclonal antibodies. Rabbit antimouse Ig-HRPO conjugate (from Sigma) was used as second antibody in the tube ELISA. Rabbit anti-mouse Ig-FITC from Sigma or Goat anti-mouse Ig-mouse Ig-FITC from Gibco BRL were used as second antibody in flow-cytmetric studies.
Tumor cell lines
Murine cell lines YAC (ATCC, TIB160), EL-4 (ATCC, TIB 39) and BW5147 (ATC, TIB47) all T-cell lymphomas, and L929 (ATCC, CCLI) fibroblast cell line, were originally obtained ATCC. All these lines were maintained and propagated by serial transfers in complete medium.
Estimation of cell surface antigens on tumor cell lines
The cell surface antigens on tumor cell lines were estimated by using a modifies cell ELISA technique or by flowcytometry as described elsewhere (Sarin and Saxena 1990) . Br i e f l y, for ELISA based estimation, cells were incubated with 200 μl of anti-MHC monoclonal antibody on ice for 30 minutes and washed twice with PBS. Appropriately diluted second antibody (0.2 ml) was added to the cells and the incubation on ice continued for 45 min. At the end of this incubation, cells were washed three times and color developed at 37˚C by adding 0.5 ml of substrate solution (0.5% orthophenylene diamine in 0.1 M citrate phosphate buffer pH 5.2, and 10 μl of 30% H 2 O 2 ). The enzyme reaction was quenched by adding 0.1 ml 5 N H 2 S O 4 per tube and color read at 492 nm using an ELISA microplate reader. For flowcytometric studies, tumor cells were suspended in 50 μl of required hybridoma culture supernatants and incubated for 20 min at 4˚C. Cells were washed once with cold PBS and suspended in 50 μl of the appropriate dilution of the second antibody-FITC conjugate. After 20 min incubation at 4˚C, cells were washed and fixed in 1 ml of 1% (w/v) paraformal-dehyde in PBS. Stained and fixed cells were analyzed on a flow cytometer (Coulter-EPICS-XL model).
IFN bioassay
Bioassay for antiviral activity of IFN was carried out using L929/VSV system as described earlier (Saxena et al. , 1988b) . One unit of interferon corresponded to half protection of L929 cells.
Preparation of mouse MHC-AF
Spleen cells (5 million cells/ml) from Balb/c or C57BI/6 mice were cultured with spleen cells from Swiss mice in RPMI-1640 medium containing 2% FCS or in DCCM-2 serum free medium. After 5 days MLR culture supernatants were harvested and precipitated by adding ammonium sulphate (85% saturation, overnight at 4˚C). Precipitated proteins were dissolved in deionized water, dialyzed two changes of 0.1 M glycine-HCI buffer pH 2.0 followed by two change of PBS and concentrated on Amicon 3K membrane filter to about 30 ml for each liter of the starting material. Protein estimations were done by the method of Bradford (1976) .
Sephadex G-100 column chromatography
10 ml of the crude MHC-AF concentrate was fractionated on a Sephadex G-100 column (25 600 mm). The column was run at 4˚C at a flow rate of 35 ml per hour in PBS and 10 ml fractions collected. Fractions with MHC-AF activity were polled and concentrated using Amicon 3 K membrane filters.
High performance liquid chromatography (HPLC)
The post Sephadex G-100 MHC-AF preparation was dialyzed against water, reconstituted with 0.1% trifluoroacetic acid (TFA) and and fractionated on a Delta Pak C18 reverse phase column (3.9 mm 150 mm) from Waters. The elution solvents were 0.1% TFA (Solvent-A) and 80% acetonitrile containing 0.1% TFA (Solvent-B). The reverse phase column was eluted with a linear gradient of 1-100% solvent-B in 40 min. The fractions of reverse phase run were lyophilized, redissolved in PBS, and assayed for MHC-AF activity.
2-D Gel electrophoresis
2-D-gel electrophoresis of MHC-AF was carried out on Mighty small gel apparatus from Hoefer, according to the manufacturer's instructions. reaction and the culture supernatants harvested on day 5 were dialyzed against pH 2.0 to deactivate any IFN-γ, and checked for their effect on the expression of class I MHC antigens on different tumor cell lines. Results in Figure 1 show that MLR supernatants caused a marked increase in the expression of class I MHC antigens on YAC, EL-4 and BW5147 cell lines. This biological activity was termed MHC augmenting factor or MHC-AF. Partially purified preparations of MHC-AF were derived from MLR supernatants by ammonium sulfate precipitation (85% saturation) followed by fractionation on Sephadex G-100 column. Elution profile of MHC-AF on Sephadex G100 column is shown in Figure 2A . From the positions of elution of marker proteins from the Sephadex column the molecular weight of MHC-AF appears to be approximately 18 kDa. The fractions with MHC-AF activity were pooled and concentrated using an Amicon 5K cut off membrane, to the origonal loading volume. This preparation was used as MHC-AF in the experiments that follow. As a control, RPMI-1640 medium (with 2% FCS) was also fractionated on a Sephadex G-100 column, but in this case, none of the column fractions showed any MHC-AF activity ( Figure  2B ). Results in Figure 3A show that MHC-AF induced a dose-dependent increase in the expression of class I MHC antigens on YAC and BW5147 tumor cell lines. There was a concomitant decline in viable cell numbers in the cultures treated with MHC-AF. A time kinetic of MHC-AF effcet is shown in Figure 3B . These results showed that MHC-AF induced significant increase in the class I MHC expression of YAC, after 12 h of treatment. 
Results
Upregulation of MHC class I antigen expression by MLR supernatants
Relationship between MHC-AF and IFN-
I F N -γ was present in fresh MLR supernatants, but dialysis of MLR supernatants against 0.1 M glycine-HCl buff e r pH-2.0 for 48 h abrogated all antiviral activity (Table 1) . These results indicate that all IFN activity in MLR supernatants was due to IFN-γ which is pH 2.0 labile, all other species of IFN being pH 2.0 stable. MHC-AF preparations were routinely dialyzed against pH 2.0 buffer and were devoid of any antiviral activity indicating the absence of biologically active IFN in these preparations.
Comparsion of potencies of MHC-AF and IFN-
IFN-γ and MHC-AF preparations were tested at different doses to assess their relative potencies in augmenting class I MHC antigen expression on YAC and EL-4 tumor cells. IFN-γ induced a maximum 2 to 2.5 fold increase in class I MHC antigen expression on YAC cells at a concen-tration of about 100U/ml (Figure 4) . MHC-AF induced increase in class I MHC antigen expression (upto 4 fold) was significantly greater than the effect of IFN-γ.
Lack of neutralization of MHC-AF activity by anti IFN antibodies
In order to further confirm MHC-AF as an entity distinct from IFN, the effect of anti-mouse IFN-γ antibodies, on MHC-AF activity was studied. Results in Figure 5 showed that anti IFN-γ antibody preparation could neutralize the effect of IFN-γ on upregulation of class I MHC antigen expression on YAC, but this reagent could not block the effects of MHC-AF.
Effect of Heat treatment on MHC-AF activity
In order to assess whether MHC-AF is a macromolecule susceptible to heat denaturation, MHC-AF preparations MHC-AF preparations were incubated with or without trypsin or chymotrypsin coupled Sepharose CL-4B beads at 37˚C for 2 h. After the incubation chymotrypsin beads were removed from MHC-AF preparation by centrifugation. Augmentation of MHC I antigen expression in response to control and trypsin-or chymotrypsin-treated MHC-AF preparation (20% (v/v)) was examined by cell ELISA technique described in 'Materials and Methods'. were incubated at 37˚C, 56˚C, or 72˚C for 45 min and tested for their effects on class I MHC of YAC. Results in Figure 6 showed that MHC-AF preparations were stable at 37˚C but lost 90-100% activity at 72˚C. Treatment at 56˚C resulted in a partial loss of MHC-AF activity. These results indicated that MHC-AF was deactivated at 72˚C.
Sensitivity of MHC-AF to proteolytic enzyme
In order to determine the susceptibility of MHC-AF to proteolytic enzymes, MHC-AF preparations were incubated with or without Sepharose CL-4B beads coupled to trypsin or chymotrypsin at 37˚C for 2 h. After the incubation, beads were removed by centrifugation and MHC-AF assay carried out. Results in Table 2 showed that MHC-AF preparations treated with trypsin or chymotrypsin, lost their ability to augment the class I MHC expression on YAC. These expreiments indicated that MHC-AF activity resided in a molecule that was protein-like in nature.
Purification of MHC-AF
Since MLR supernatants were generated using culture medium containing fetal calf serum, protein concentration of MHC-AF preparations was very high, and number of irrelevant proteins was very large. In order to purify the MHC-AF activity, it was important to start with preparations with least amount of irrelevant proteins. For this purpose, MHC-AF was generated in DCCM-2 serum free medium, processed upto Sephadex G-100 step as described above and further fractionated on reverse phase HPLC. D C C M -2 medium has previously been shown to be optimal for MHC-AF production of human MHC-AF . Figure 7 showed the elution profile of MHC-AF on reverse phase column. MHC-AF eluted towards the end of the gradient whereas bulk of the proteins without biological activity eluted earlier. The fractions with MHC-AF activity were pooled and 25 μg protein was subjected to 2D gel electrophoresis to check the heterogeneity of this preparation. 2D gel profile of post RP HPLC MHC-AF preparation is given in Figure 8 and indicated the level of heterogeneity of MHC-AF preparation after the purification step.
Discussion
In the present study we have shown that MLRs of spleen cells from allogenic strains of mice, contain a soluble factor(s) which augments the expression of class I MHC molecules on some tumor cell lines. Expression of class I MHC antigens is also enhanced by IFN-γ (Rosa and Fellows 1984) , which is known to be released by activated T cells and NK cells. An obvious question therefore is whether MHC-AF activity could be attributed to IFN-γ. There are several lines of experimental evidence which indicate that MHC-AF is distinct from IFN (Saxena et al., 1988a , Puri et al., 1997 . In the present study, with MLR supernatants, mouse MHC-AF preparations are routinely dialyzed against pH 2.0 for 48 h at 4˚C, a treatment known to deactivate IFN-γ (Farrar and Schreiber 1993) . After this step, IFN activity was reduced to less than 0.1 U/ml in mouse MHC-AF preparations. IFN-γ at this dose level, has no effect on MHC I expression of YAC cells. By being acid stable, mouse MHC-AF appeared to be distinct from IFN-γ. We could also demonstrate that anti-IFN-γ monoclonal antibody, had no effect on the activity of MHC-AF. Taken together, these results indicate that MHC-AF is distinct from IFN-γ. We however, cannot rule out the possibilities that a degradation product of IFN-γ or a truncated form of IFN-γ, lacking antiviral activity, but having class I MHC inducing activity and unreactive with a n t i -I F N -γ antibodies, is responsible for MHC-AF activity.
Using gel chromatography on a calibrated Sephadex G-100 column, the molecular weight of MHC-AF was estimated to be 18 kDa. MHC-AF activity was destroyed at 72˚C for 45 min. This indicated, that MHC-AF could be a macromolecule denatured by heating. Further c h a r a c -terization indicated that MHC-AF activity was abolished by treatment with proteolytic enzymes, trypsin and chymo-trypsin. Therefore, MHC-AF activity appeared to reside in a protein molecule that contains basic as well as aromatic amino acids.
Cytokines are generally released into the culture media in extremely low concentrations ranging from few pg to few ng per ml. We initially generated MHC-AF in culture medium containing fetal calf serum which had a very high concentration of a very large number of proteins. We realized that purification of MHC-AF from serum containing medium would be very difficult, and therefore we shifted to a serum free culture medium. DCCM-2 medium we used for this purpose contained three defined p r o t e i n s (Albumin, Transferrin and Insulin). MHC-AF prepared and purified from DCCM-2 medium up to reverse phase HPLC column still had protein heterogeneity as shown by 2D gel electrophoresis. Further purification, characterization and sequencing studies on MHC-AF will require to access sufficient quantities of MHC-AF. It would require suitable scale-up of production and purification operations, which have been standardized on a laboratory scale in the present study.
